RYANODEX Trademark

Trademark Overview

On Wednesday, February 8, 2017, a trademark application was filed for RYANODEX with the United States Patent and Trademark Office. The USPTO has given the RYANODEX trademark a serial number of 87328847. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 22, 2021. This trademark is owned by Lytropic Therapeutics, Inc.. The RYANODEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, dantrolene preparations for pharmaceutical purposes for hypothermia and exertional heat stroke
ryanodex

General Information

Serial Number87328847
Word MarkRYANODEX
Filing DateWednesday, February 8, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 22, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 19, 2017

Trademark Statements

Indication of Colors claimedThe color(s) blue and orange is/are claimed as a feature of the mark.
Description of MarkThe mark consists of a ribbon design in blue and orange colors; to the left of the design is the word "RYANODEX" in blue color.
Goods and ServicesPharmaceutical preparations, namely, dantrolene preparations for pharmaceutical purposes for hypothermia and exertional heat stroke

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 13, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLytropic Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAshland, VA 23005
Party NameLytropic Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAshland, VA 23005

Trademark Events

Event DateEvent Description
Monday, March 22, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 22, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 18, 2020EXTENSION 5 GRANTED
Friday, August 7, 2020EXTENSION 5 FILED
Tuesday, August 18, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 7, 2020TEAS EXTENSION RECEIVED
Thursday, July 23, 2020ASSIGNED TO EXAMINER
Saturday, February 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 13, 2020EXTENSION 4 GRANTED
Thursday, February 13, 2020EXTENSION 4 FILED
Thursday, February 13, 2020TEAS EXTENSION RECEIVED
Tuesday, August 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 9, 2019EXTENSION 3 GRANTED
Friday, August 9, 2019EXTENSION 3 FILED
Friday, August 9, 2019TEAS EXTENSION RECEIVED
Tuesday, January 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 18, 2019EXTENSION 2 GRANTED
Friday, January 18, 2019EXTENSION 2 FILED
Friday, January 18, 2019TEAS EXTENSION RECEIVED
Friday, August 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 8, 2018EXTENSION 1 GRANTED
Wednesday, August 8, 2018EXTENSION 1 FILED
Wednesday, August 8, 2018TEAS EXTENSION RECEIVED
Tuesday, February 13, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 29, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 15, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 7, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 7, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 2, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 26, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 26, 2017NON-FINAL ACTION E-MAILED
Thursday, October 26, 2017NON-FINAL ACTION WRITTEN
Saturday, October 21, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, October 10, 2017WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, September 28, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 25, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 25, 2017EXAMINER'S AMENDMENT ENTERED
Monday, September 25, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, September 25, 2017EXAMINERS AMENDMENT E-MAILED
Monday, September 25, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, September 7, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 7, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 31, 2017ASSIGNED TO LIE
Tuesday, August 15, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, May 5, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 5, 2017NON-FINAL ACTION E-MAILED
Friday, May 5, 2017NON-FINAL ACTION WRITTEN
Wednesday, May 3, 2017ASSIGNED TO EXAMINER
Tuesday, February 14, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, February 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 13, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

ryanodex pharmaceutical preparations heat stroke exertional purposes namely dantrolene hypothermia